Cargando…
Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma
Current risk stratification schemas for medulloblastoma, based on combinations of clinical variables and histotype, fail to accurately identify particularly good- and poor-risk tumors. Attempts have been made to improve discriminatory power by combining clinical variables with cytogenetic data. We r...
Autores principales: | McCabe, Martin G., Bäcklund, L. Magnus, Leong, Hui Sun, Ichimura, Koichi, Collins, V. Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064691/ https://www.ncbi.nlm.nih.gov/pubmed/21292688 http://dx.doi.org/10.1093/neuonc/noq192 |
Ejemplares similares
-
Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis
por: Muskens, Ivo S, et al.
Publicado: (2020) -
Characterization of G-CSF receptor expression in medulloblastoma
por: Paul, Megan Rose, et al.
Publicado: (2020) -
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
por: Richardson, Stacey, et al.
Publicado: (2021) -
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021) -
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2022)